Drugs / Desipramine
last change Jun 2024 re-read 2 minutes ago

Desipramine

Small molecule targets SLC6A2 via inhibition

Developed for
depressive disorder · major depressive disorder · cocaine abuse · irritable bowel syndrome · alcohol dependence · chronic pain syndrome · constipation disorder · dyspepsia
+11 more · functional colonic disease · gastroesophageal reflux disease · infantile axonal neuropathy · obstructive sleep apnea syndrome · Rett syndrome · schizophrenia · sciatica · small cell lung carcinoma · substance-related disorder · vulvar disease · post-traumatic stress disorder
Investigated by
National Institute on Drug Abuse (NIDA) · National Institute of Mental Health (NIMH) · New York State Psychiatric Institute · Wyeth is now a wholly owned subsidiary of Pfizer · Friends Research Institute, Inc. · Sandoz
+27 more · US Department of Veterans Affairs · VA Office of Research and Development · Albert Einstein College of Medicine · Assistance Publique Hopitaux De Marseille · Astellas Pharma Inc · Boehringer Ingelheim · Brigham and Women's Hospital · Columbia University · Dartmouth-Hitchcock Medical Center · Duke University · Eli Lilly and Company · Harvard Medical School (HMS and HSDM) · Joel Neal · Michigan State University · National Cancer Institute (NCI) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National Institute of General Medical Sciences (NIGMS) · Stanford University · Temple University · University of California, San Diego · University of Massachusetts, Worcester · University of Pennsylvania · University of Rochester · University of South Carolina · Vertex Pharmaceuticals Incorporated · ViroPharma · Washington University School of Medicine

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) NORPRAMIN 1976-06-25 fda.gov
Approved US (FDA) NORPRAMIN 1964-11-20 fda.gov

Trials 32 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 17 trials
Phase 1 NCT01358968 Jun 2011 → Apr 2012 cancer Eli Lilly and Company Completed No outcome recorded
Phase 1 NCT01153542 Jun → Aug 2010 cystic fibrosis Vertex Pharmaceuticals Incorporated Completed No outcome recorded
Phase 1 NCT01478568 Oct 2008 → Jan 2009 Astellas Pharma Inc Completed No outcome recorded
Phase 1 NCT00500721 Jun → Aug 2007 Wyeth is now a wholly owned subsidiary of Pfizer Completed No outcome recorded
Phase 1 NCT02273466 Feb → Apr 2002 Boehringer Ingelheim Completed No outcome recorded
Phase 1 NCT00913822 Dec 1987 depressive disorder Sandoz Completed No outcome recorded
Phase 1 NCT00913237 Jul → Aug 1987 depressive disorder Sandoz Completed No outcome recorded
Phase 210 trials
Phase 2 NCT02436031 Apr → Dec 2015 obstructive sleep apnea syndrome Brigham and Women's Hospital Completed No outcome recorded
Phase 2 NCT01719861 Oct 2012 → May 2014 small cell lung carcinoma Joel Neal Terminated No outcome recorded
Phase 2 NCT01411085 Dec 2011 → Aug 2014 alcohol dependence, schizophrenia Dartmouth-Hitchcock Medical Center Completed No outcome recorded
Phase 2 NCT00964886 Jan 2010 → Dec 2014 VA Office of Research and Development Completed No outcome recorded
Phase 2 NCT00990691 Feb 2009 → Aug 2014 Rett syndrome Assistance Publique Hopitaux De Marseille Completed No outcome recorded
Phase 2 NCT00265291 Nov 1999 → May 2006 major depressive disorder National Institute of General Medical Sciences (NIGMS) Completed No outcome recorded
Phase 2 NCT00018200 Apr 1999 → Dec 2003 sciatica US Department of Veterans Affairs Completed No outcome recorded
Phase 2 NCT00000271 Jan 1995 → Oct 2002 cocaine abuse New York State Psychiatric Institute Completed No outcome recorded
Phase 2 NCT00000245 May 1994 → Dec 2001 cocaine abuse National Institute on Drug Abuse (NIDA) Completed No outcome recorded
Phase 2 NCT00000212 Jul 1987 → Jul 1988 cocaine abuse New York State Psychiatric Institute Completed No outcome recorded
Phase 34 trials
Phase 3 NCT01265550 Aug 2012 → Dec 2016 gastroesophageal reflux disease VA Office of Research and Development Completed No outcome recorded
Phase 3 NCT00366652 Sep 2006 major depressive disorder Wyeth is now a wholly owned subsidiary of Pfizer Completed No outcome recorded
Phase 3 NCT00329147 May → Jun 2006 depressive disorder Wyeth is now a wholly owned subsidiary of Pfizer Completed No outcome recorded
Phase 3 NCT00006157 Jul 1996 → Mar 2001 constipation disorder, functional colonic disease, irritable bowel syndrome National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Completed No outcome recorded
Phase 44 trials
Phase 4 NCT03726996 Jan → Aug 2019 infantile axonal neuropathy Duke University Terminated No outcome recorded
Phase 4 NCT03548454 Sep 2018 → Dec 2023 chronic pain syndrome Stanford University Completed No outcome recorded
Phase 4 NCT00000321 Oct 1996 → Dec 2001 substance-related disorder National Institute on Drug Abuse (NIDA) Completed No outcome recorded
Phase 4 NCT00320632 Aug 1990 → Jul 1993 depressive disorder Harvard Medical School (HMS and HSDM) Completed No outcome recorded
Phase not applicable7 trials
NCT01899326 Sep 2013 → Mar 2015 plasma cell myeloma Albert Einstein College of Medicine Terminated No outcome recorded
NCT00880594 Feb 2009 → Nov 2014 irritable bowel syndrome Washington University School of Medicine Terminated No outcome recorded
NCT00456014 Sep 2006 → May 2012 major depressive disorder New York State Psychiatric Institute Completed No outcome recorded
NCT00220844 Sep 2005 → Jun 2014 dyspepsia Temple University Terminated No outcome recorded
NCT00276068 Aug 2002 → Sep 2007 vulvar disease University of Rochester Completed No outcome recorded
NCT00018733 Sep 1996 → Dec 2001 depressive disorder US Department of Veterans Affairs Completed No outcome recorded
NCT00000376 Mar 1996 → Feb 1999 anxiety disorder, major depressive disorder, personality disorder University of Pennsylvania Completed No outcome recorded
Also used as a comparator or background therapy in 5 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01415128 Comparator Apr → May 2010 erectile dysfunction VIVUS LLC Completed No outcome recorded
Phase 21 trial
Phase 2 NCT02428478 Comparator Mar → Nov 2015 obstructive sleep apnea syndrome Brigham and Women's Hospital Completed No outcome recorded
Phase 32 trials
Phase 3 NCT00338962 Comparator Oct 2001 → Jul 2015 alcohol dependence, depressive disorder, post-traumatic stress disorder Yale University Completed No outcome recorded
Phase 3 NCT00004390 Background Feb 1995 → ? postherpetic neuralgia National Center for Research Resources (NCRR) Completed No outcome recorded
Phase 41 trial
Phase 4 NCT00166114 Comparator Feb 2002 → Jan 2009 major depressive disorder Emory University Completed No outcome recorded

Evidence & citations 21 cited values

Every value below carries the sentence it was read from. 39 sources stand behind the page.

FieldValueCited text
Known as Desipramine “The current study compared the serotonin uptake inhibitor, paroxetine, to the norepinephrine uptake inhibitor, desipramine.” PMID 22089316 Nov 2011
35

“In period 1, subjects will receive a single oral dose of desipramine on Day 1.” NCT01153542

NCT00913822

NCT00366652

NCT00000376

NCT01358968

NCT00265291

NCT01415128

NCT00018733

NCT00166114

NCT00220844

NCT03548454

NCT00913237

NCT03726996

NCT00456014

NCT01719861

NCT01411085

NCT02273466

NCT00000245

NCT00000321

NCT02436031

NCT01265550

NCT00500721

NCT02428478

NCT00004390

NCT00880594

NCT00018200

NCT00329147

NCT01478568

NCT00006157

NCT00964886

NCT00000212

NCT00276068

NCT00000271

NCT00990691

NCT00320632

Known as 18-8181 ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as Desipramina ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as Desipramine hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as Desipramine Hydrochloride desipramine hydrochloride, with dose targeted to achieve a serum concentration of 5-60ng/ml” NCT00964886
3

Desipramine Hydrochloride 100 mg Tablets (Cord Laboratories)” NCT00913822

Desipramine Hydrochloride 50 mg Tablets (Cord Laboratories)” NCT00913237

NCT01899326

Known as DMI “The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including...” NCT00000212
1

“using the standard antidepressant desipramine (DMI)” NCT00000376

Known as EX 4355 ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as G-35020 ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as JB-8181 ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as Monodemethylimipramine ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as N-desmethylimipramine ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as Norimipramine ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as Norpramin ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as NSC-114901 ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as Pertofran ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as Pertofrane ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Known as RMI 9,384A ChEMBL registry synonym — accepted as the source's own label CHEMBL72
Action Inhibit “a norepinephrine (desipramine) and a serotonin reuptake (fluoxetine) inhibitor” PMID 17414235 Apr 2007
1

“Norepinephrine transporter inhibitor” CHEMBL72

Modality Small molecule “Desipramine is a tricyclic antidepressant” NCT00276068
Route Oral oral consumption of the study agent” NCT00220844
Target SLC6A2 “Norepinephrine transporter inhibitor” CHEMBL72